ID

14338

Descrizione

Indoor Air Pollution and Children With Asthma: An Intervention Trial; ODM derived from: https://clinicaltrials.gov/show/NCT02258893

collegamento

https://clinicaltrials.gov/show/NCT02258893

Keywords

  1. 11/04/16 11/04/16 -
Caricato su

11 aprile 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :


Non ci sono commenti

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Asthma NCT02258893

Eligibility Asthma NCT02258893

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT02258893
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
5-11 years of age, enrolled in grades k-5 and living in one of 16 selected towns
Descrizione

Age | Town environment

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0557750
[the screening questionnaire will determine asthma symptoms in the past 12 months (wheeze, persistent cough, shortness of breath, chest tightness); and asthma medication use in the past 12 months (short-acting β2-agonists, long-acting
Descrizione

Asthma Symptoms | Rhonchi | Persistent cough | Dyspnea | Chest tightness | Pharmaceutical Preparations Asthma | Adrenergic beta-2 Receptor Agonists

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C1457887
UMLS CUI [2]
C0035508
UMLS CUI [3]
C0562483
UMLS CUI [4]
C0013404
UMLS CUI [5]
C0232292
UMLS CUI [6,1]
C0013227
UMLS CUI [6,2]
C0004096
UMLS CUI [7]
C2936789
β2-agonists, inhaled steroids, oral steroids, theophylline, cromones, and/or leukotriene inhibitors). based on symptoms and medication, asthma severity will be categorized with a score adapted from the global initiative for asthma guidelines (1=mild transient, 2=mild persistent, 3=moderate, 4=severe). only children in categories 2 (mild persistent, 3 (moderate) or 4 (severe) will be eligible.]
Descrizione

Adrenergic beta-2 Receptor Agonists | inhaled steroids | Adrenal Cortex Hormones | Theophylline | Chromones | Leukotriene Antagonists | Mild persistent asthma | Moderate persistent asthma | Severe persistent asthma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2936789
UMLS CUI [2]
C2065041
UMLS CUI [3]
C0001617
UMLS CUI [4]
C0039771
UMLS CUI [5]
C0008594
UMLS CUI [6]
C0595726
UMLS CUI [7]
C1960046
UMLS CUI [8]
C1960047
UMLS CUI [9]
C1960048
for potential subjects satisfying these inclusion criteria, a passive no2 monitor will be sent to the home for placement in the main living space for one week. families will be called after one week and instructed to cap and return the no2 monitor in a pre-paid mailer. families of children living in homes where the one-week integrated average no2 concentration is > 20 ppb will be invited to participate. we will permit the enrollment of more than one eligible child per family.
Descrizione

Patient Monitoring Home environment | Study Subject Participation Status

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0030695
UMLS CUI [1,2]
C0442519
UMLS CUI [2]
C2348568
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
not using steroid medication for a condition other than asthma
Descrizione

Steroids Pharmaceutical Preparations | Asthma

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0038317
UMLS CUI [1,2]
C0013227
UMLS CUI [2]
C0004096
no chronic respiratory condition other than asthma
Descrizione

Respiration Disorders | Asthma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0035204
UMLS CUI [2]
C0004096
no intention to move or relocate within 6 months
Descrizione

Relocation of home Planned

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2699029
UMLS CUI [1,2]
C1301732

Similar models

Eligibility Asthma NCT02258893

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT02258893
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Age | Town environment
Item
5-11 years of age, enrolled in grades k-5 and living in one of 16 selected towns
boolean
C0001779 (UMLS CUI [1])
C0557750 (UMLS CUI [2])
Asthma Symptoms | Rhonchi | Persistent cough | Dyspnea | Chest tightness | Pharmaceutical Preparations Asthma | Adrenergic beta-2 Receptor Agonists
Item
[the screening questionnaire will determine asthma symptoms in the past 12 months (wheeze, persistent cough, shortness of breath, chest tightness); and asthma medication use in the past 12 months (short-acting β2-agonists, long-acting
boolean
C0004096 (UMLS CUI [1,1])
C1457887 (UMLS CUI [1,2])
C0035508 (UMLS CUI [2])
C0562483 (UMLS CUI [3])
C0013404 (UMLS CUI [4])
C0232292 (UMLS CUI [5])
C0013227 (UMLS CUI [6,1])
C0004096 (UMLS CUI [6,2])
C2936789 (UMLS CUI [7])
Adrenergic beta-2 Receptor Agonists | inhaled steroids | Adrenal Cortex Hormones | Theophylline | Chromones | Leukotriene Antagonists | Mild persistent asthma | Moderate persistent asthma | Severe persistent asthma
Item
β2-agonists, inhaled steroids, oral steroids, theophylline, cromones, and/or leukotriene inhibitors). based on symptoms and medication, asthma severity will be categorized with a score adapted from the global initiative for asthma guidelines (1=mild transient, 2=mild persistent, 3=moderate, 4=severe). only children in categories 2 (mild persistent, 3 (moderate) or 4 (severe) will be eligible.]
boolean
C2936789 (UMLS CUI [1])
C2065041 (UMLS CUI [2])
C0001617 (UMLS CUI [3])
C0039771 (UMLS CUI [4])
C0008594 (UMLS CUI [5])
C0595726 (UMLS CUI [6])
C1960046 (UMLS CUI [7])
C1960047 (UMLS CUI [8])
C1960048 (UMLS CUI [9])
Patient Monitoring Home environment | Study Subject Participation Status
Item
for potential subjects satisfying these inclusion criteria, a passive no2 monitor will be sent to the home for placement in the main living space for one week. families will be called after one week and instructed to cap and return the no2 monitor in a pre-paid mailer. families of children living in homes where the one-week integrated average no2 concentration is > 20 ppb will be invited to participate. we will permit the enrollment of more than one eligible child per family.
boolean
C0030695 (UMLS CUI [1,1])
C0442519 (UMLS CUI [1,2])
C2348568 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Steroids Pharmaceutical Preparations | Asthma
Item
not using steroid medication for a condition other than asthma
boolean
C0038317 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0004096 (UMLS CUI [2])
Respiration Disorders | Asthma
Item
no chronic respiratory condition other than asthma
boolean
C0035204 (UMLS CUI [1])
C0004096 (UMLS CUI [2])
Relocation of home Planned
Item
no intention to move or relocate within 6 months
boolean
C2699029 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial